SEC FORM 4
$210,478.39
UNITED THERAPEUTICS Corp (UTHR)
Sale of 360 shares at $584.6622 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →